Studies on quinoline and isoquinoline derivatives. VIII. Hydration and hydrogenation of ethynyl substituents attached to the pyridine moiety of quinoline and isoquinoline rings

DOI: 10.1248/cpb.29.3554

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 3554 - 3560 (1981)

Update date:2022-08-02

Topics:

Authors:

Konno Konno

Shiraiwa

Yamanaka

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.29.3554

Full text of DOI:10.1248/cpb.29.3554

NII-Electronic Library Service

Products guided by the article

Product name:2-Isoquinolin-3-yl-1-phenyl-ethanone

Cas No:80998-84-1

R&D Labs maybe for 80998-84-1

Beijing Tianjia Chemical Science & Technology Co.,Ltd

Contact:86-0550-2392698

Address:No.388, Shiliang Road (East),
Tianjin Tongde Biological Technology Co., Ltd.

Contact:86-22-23309138

Address:Room 402, bulidingE3 Detection certification park, XiQingDistrict, Tianjin City
CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD

website:http://www.czyys.com

Contact:0086-519-88802789

Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
SYN Pharma Co., Ltd

Contact:86-21 60347964

Address:No.1304, West Meilong Road, Minhang District, Shanghai, China
Chengdu Push Bio-technology Co., Ltd

Contact:--

Address:No.8 Wuke West Second Road, Wuhou

Relevant to this article

Doi:10.1016/S0020-1693(00)88578-3
(1981)
Tricyclic Heteroaromatic Ring Systems III. Synthesis of 1H,6H-Dipyrazolo<3,4-b:3',4'-d>pyridin-3-ones

Doi:10.1007/BF00814345
(1982)
On the reactivity of isoxazoles with Mo(CO)₆

Doi:10.1002/jhet.5570410518
(2004)
Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from Hit to Clinic

Doi:10.1021/jm2007062
(2011)
Syntheses of derivatives of lacto-N-biose. I. 4,6-Di-O-acetyl-3-O-(tetra-O-acetyl-β-D-galactopyranosyl)-2-deoxy-2-phthalimido-α,β-D-glucopyranosyl chloride

Doi:10.1139/v82-010
(1982)
Synthesis and autooxidative transformation of 2-(2-aminophenyl)-4-hydroxy-3-phenyl-1-isoquinolone

Doi:10.1007/BF00513293
(1982)

Article Doi